Funded Tech Companies

Trivascular Technologies

Wondering who provided funding to Trivascular Technologies? Kaiser Permanente Ventures, Deerfield Capital and Permal Capital joined the equity holders in this medical devices company.

Company Overview

Contact Information

Company Background Information

Overview

Trivascular Technologies is developing novel endovascular repair devices to treat abdominal aortic aneurysms (AAA).

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/18/2013

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Christopher Chavez

        

Chief Financial Officer

Michael Kramer

        

Chief Technical Officer

Michael Chobotov

        

VP - General Counsel

Kimberley Elting

        

VP - Manufacturing

Joseph Humphrey

        

VP - Operations

Vivek Jayaraman

        

VP - R & D

Robert Whirley

        

VP - Regulatory Affairs

Shari Quinn

        

VP - Sales

Rob Woolley

        

Company Investors

• Kaiser Permanente Ventures (Sam Brasch)
• Deerfield Capital
• Permal Capital
• New Enterprise Associates (Ryan Drant)
• Rock Springs Capital
• Kearny Venture Partners (James Shapiro)
• MPM Capital (James Scopa)
• Delphi Ventures (Douglas Roeder)
• Redmile Group
• Pinnacle Ventures (David Kim)
• New Enterprise Associates (Jake Nunn)

Browse more funded tech companies:

Trius Therapeutics | Triveni Bio

Share this article

About Our VC Transaction Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary